Highlights Neuronetics, Inc.

Stocks

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 10/07/2026 BST			5-day change	1st Jan Change
1.760 ^USD	+6.02%		+24.82%	+27.54%

06-29	Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Dynamic Index	CI
06-29	Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000E Index	CI

Highlights

05-14	Neuronetics and Ant Neuro Enter Strategic Collaboration to Integrate Neuronavigation with Neurostar Tms Treatment	CI
05-05	Neuronetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2026	CI
04-13	Neuronetics, Inc. Highlights Optum/UHC/UBH TMS Policy Expansion Enabling PMHNPs To Deliver NeuroStar Therapy Across 26 States And Washington D.C	CI
04-06	Jorey Chernett Calls for Immediate and Comprehensive Review of Strategic Alternatives at Neuronetics	CI
03-17	Neuronetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-17	Neuronetics, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026	CI
11-04	Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-04	Neuronetics, Inc. Provides Revenue Guidance for the Fourth Quarter 2025	CI
11-04	Neuronetics, Inc. Revises Earnings Guidance for the Full Year 2025	CI
11-04	Neuronetics Q3 revenue misses estimates	RE
30/10/25	Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand Neurostar Access and Operational Excellence	CI
05/08/25	Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
05/08/25	Healthcare firm Neuronetics Q2 revenue beats estimates	RE
05/08/25	Neuronetics, Inc. Provides Earnings Guidance for the Third Quarter and Full Year Ending December 31, 2025	CI
15/07/25	Neuronetics appoints new chief financial officer	RE
06/05/25	Neuronetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
06/05/25	Neuronetics, Inc. Revises Earnings Guidance for the Full Year 2025	CI
06/05/25	Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter of 2025	CI
27/03/25	Neuronetics Some Non-Cash Revisions Made To Financial Statements Related To Co's Acquisition Of Greenbrook Tms & Shares Outstanding In Q4	RE
04/03/25	Neuronetics, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025	CI
04/03/25	Neuronetics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
07/02/25	Neuronetics Seeks Acquisitions	CI
07/02/25	Neuronetics Prices Eight Million Share Offering at $2.25 Per Share	MT
29/01/25	Neuronetics, Inc. Unveils Two Significant Publications on TMS Therapy for Depression	CI